Meri Rogava
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cutaneous Melanoma Detection and Management
Papers in
-
- Immunotherapy and Immune Responses 4
- interferon and immune responses 2
- T-cell and B-cell Immunology 2
- Immune cells in cancer 2
- Immune Cell Function and Interaction 2
- Mast cells and histamine 1
- Oncology 5
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Thomas Tüting (4 shared papers)Michael Hölzel (3 shared papers)Tobias Bald (3 shared papers)Jennifer Landsberg (2 shared papers)Marcel Renn (1 shared paper)Judith Kohlmeyer (1 shared paper)Mira Cron (1 shared paper)Martina Fatho (1 shared paper)
- Journals
- Cancer Research (2 papers)Nature (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Cells (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Meri Rogava
6 papers receiving 509 citations
Peers
Comparison fields: 5 of 65
- Immunology 291
- Oncology 320
- Cancer Research 55
- Molecular Biology 217
- Immunology and Allergy 16
Countries citing papers authored by Meri Rogava
This map shows the geographic impact of Meri Rogava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meri Rogava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meri Rogava more than expected).
Fields of papers citing papers by Meri Rogava
This network shows the impact of papers produced by Meri Rogava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meri Rogava. The network helps show where Meri Rogava may publish in the future.
Co-authors
The 25 scholars most cited alongside Meri Rogava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 448 | |
| 2 | 2015 | 30 | |
| 3 | 2024 | 18 | |
| 4 | 2021 | 8 | |
| 5 | 2023 | 7 | |
| 6 | 2021 | 5 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 |
About Meri Rogava
Meri Rogava is a scholar working on Immunology, Oncology, Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 8 papers that have together received 516 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers), interferon and immune responses (2 papers), T-cell and B-cell Immunology (2 papers), Immune cells in cancer (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Immunology (291 citations), Oncology (320 citations), Cancer Research (55 citations), Molecular Biology (217 citations) and Immunology and Allergy (16 citations). Meri Rogava has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Thomas Tüting, Michael Hölzel, Tobias Bald, Jennifer Landsberg, Marcel Renn, Judith Kohlmeyer, Mira Cron, Martina Fatho, Volker Lennerz and Thomas Wölfel. Their work appears in journals such as Cancer Research, Nature, Journal for ImmunoTherapy of Cancer, Cells and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.